Literature DB >> 6110526

Copper deficiency in humans.

D M Danks.   

Abstract

Copper deficiency of nutritional origin has been recognized as an important part of complex nutritional problems in Peru, as an occasional even in premature babies in Western countries, and as a real hazard of over-zealous zinc therapy or of prolonged parenteral alimentation in children or adults. Anaemia, osteoporosis and scurvy-like bone changes are recognized in the deficiency, and they respond to copper. Copper intake is falling in western countries as a result of prepackaging of foods, and low-grade chronic deficiency may become a problem. The features seen in Menkes' syndrome suggest that human beings may be rather susceptible to the vascular and neurological effects of copper deficiency; these effects may be encountered as a consequence of prolonged mild copper deficiency. Measurement of the serum concentrations of caeruloplasmin before and after moderate copper repletion is suggested as a method of detecting mild copper deficiency.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6110526     DOI: 10.1002/9780470720622.ch11

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  4 in total

1.  Pancreatic acinar cell regeneration following copper deficiency-induced pancreatic necrosis.

Authors:  M S Rao; V Subbarao; A V Yeldandi; J K Reddy
Journal:  Int J Pancreatol       Date:  1987-04

Review 2.  Of mice and men, metals and mutations.

Authors:  D M Danks
Journal:  J Med Genet       Date:  1986-04       Impact factor: 6.318

3.  Embryotoxicity of silver ions is diminished by ceruloplasmin--further evidence for its role in the transport of copper.

Authors:  M M Shavlovski; N A Chebotar; L A Konopistseva; E T Zakharova; A M Kachourin; V B Vassiliev; V S Gaitskhoki
Journal:  Biometals       Date:  1995-04       Impact factor: 2.949

4.  Hair trace elements in cerebellar degeneration: low copper levels in late cortical cerebellar atrophy.

Authors:  M Oishi; T Takasu; M Tateno; H Uchida
Journal:  J Neurol       Date:  1990-06       Impact factor: 4.849

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.